All Stories

AstraZeneca, Merck duke it out at the top of oncologists’ pharma perception ranking

AstraZeneca and Merck are still leading the pack when it comes to how oncologists perceive makers of cancer drugs, according to a new report from ZoomRx.

May 22, 2025 - 17:30
 0
AstraZeneca, Merck duke it out at the top of oncologists’ pharma perception ranking
AstraZeneca and Merck are still leading the pack when it comes to how oncologists perceive makers of cancer drugs, according to a new report from ZoomRx.
Read More

Tags:

Previous Article

CDMO Samsung Biologics telegraphs spinoff of biosim unit

Next Article

Novo offers Wegovy discount for new patients, launches new ad campaign as time r...

Related Posts

AstraZeneca's Airsupra cuts risk of severe exacerbations by 47% in patients with milder asthma

AstraZeneca's Airsupra cuts risk of severe exacerbation...

May 19, 2025  0

Supernus casts Busy Philipps as'Ms. Represented' in Qelbree campaign targeting women with ADHD

Supernus casts Busy Philipps as'Ms. Represented' in Qel...

May 21, 2025  0

Weighing approval bids from J&J, Pfizer and Roche, FDA scrutinizes data ahead of adcomm

Weighing approval bids from J&J, Pfizer and Roche, FDA ...

May 16, 2025  0